We can achieve so much more together than we can on our own—that’s why we launched our Partnership Grants in 2022. These awards, worth up to $500,000 over 2 years, support grant-making efforts at other nonprofit organizations that align with our vision and values. While some of these nonprofits work explicitly on ALS, others have a different focus but are still excited to partner with us on projects that advance the goals of both organizations.

Awardees leverage our Partnership Grants to help grow, scale or augment their own research funding programs. This builds co-funded collaborations that make the programs larger or more impactful than if our partners were pursuing them alone. These collaborations also help foster long-term working relationships, promote coordination and reduce redundancy so we can transform the ALS experience as quickly as possible.

We are not currently accepting applications for this award. Click here to explore open funding opportunities.
 

Current Partners

Through this program we have created powerful partnerships with the organizations listed below. These collective efforts are aimed at helping us understand ALS more deeply, detect ALS more quickly, treat the disease more thoroughly and someday find a cure. 

ALS Finding a Cure

In early 2023, ALS Finding a Cure and The ALS Association partnered to issue an international call for proposals designed to encourage the identification of early diagnostic markers for ALS. Learn more.

Association for Frontotemporal Degeneration

In May 2023, The ALS Association and The Association for Frontotemporal Degeneration launched a research funding opportunity supporting the collaborative development of digital assessment tools for both ALS and FTD. Learn more.

Focused Ultrasound Foundation

The ALS Association and the Focused Ultrasound Foundation are partnering to advance research into diagnosing and treating ALS using focused ultrasound technology. Learn more.

Target ALS

In May 2023, Target ALS and The ALS Association partnered to launch a new In Vivo Target Validation grant that enables the evaluation of novel therapeutics for target engagement and disease-modifying potential in ALS. Learn more.